Review




Structured Review

Jackson Laboratory primary murine bmdms
Primary Murine Bmdms, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary murine bmdms/product/Jackson Laboratory
Average 86 stars, based on 1 article reviews
primary murine bmdms - by Bioz Stars, 2026-06
86/100 stars

Images



Similar Products

86
Jackson Laboratory primary murine bmdms
Primary Murine Bmdms, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary murine bmdms/product/Jackson Laboratory
Average 86 stars, based on 1 article reviews
primary murine bmdms - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

90
Cell Biologics Inc c57bl/6 murine bone marrow-derived primary macrophages (bmdm)
C57bl/6 Murine Bone Marrow Derived Primary Macrophages (Bmdm), supplied by Cell Biologics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c57bl/6 murine bone marrow-derived primary macrophages (bmdm)/product/Cell Biologics Inc
Average 90 stars, based on 1 article reviews
c57bl/6 murine bone marrow-derived primary macrophages (bmdm) - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Charles River Laboratories primary murine bone marrow-derived macrophages (bmdm
Primary Murine Bone Marrow Derived Macrophages (Bmdm, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary murine bone marrow-derived macrophages (bmdm/product/Charles River Laboratories
Average 90 stars, based on 1 article reviews
primary murine bone marrow-derived macrophages (bmdm - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Cell Biologics Inc c57bl/6 murine bone marrow-derived primary macrophages (bmdm
Increased survival from AuNP-OpcP-LPS- or AuNP-OpcP1-LPS-immunized mice against a lethal intranasal challenge with B. pseudomallei K96243. (A) Graphical representation of the vaccination, challenge, and organ/tissue collection timeline. Two separate groups of <t>C57BL/6</t> mice (at least n = 9) were immunized intranasally 3× in 2-week intervals with formulations containing 10 μg of protein, 10 μg of LPS, and 20 μg of CpG ODN 2395. In experiment one, a combination formulation (AuNP-Combo1-LPS) included equivalent amounts of protein (Hcp1, OmpW, OpcP, OpcP1, FlgL, and HA) from each candidate for a total of 10 μg of protein. A second animal experiment (at least n = 9) was conducted to evaluate histopathology, cell-mediated response, and BALF from vaccinated-only animals. (B) In experiment one, 3 weeks after the last vaccination, animals were challenged with 6 LD 50 (9.0 × 10 4 CFU per mouse) of B. pseudomallei K96243. (C to E) Lungs (C), livers (D), and spleens (E) of surviving animals were collected at 35 days postinfection to evaluate bacterial infection. Bacterial load was determined per gram of tissue, and representative panels for colonization are shown on log scale. All colonization data are shown as means ± standard errors of the means (SEM) of results determined per group. Statistical analyses were determined using the Kaplan-Meier method, followed by log rank test. Levels of significance compared to the adjuvant-only group: ***, P < 0.001; ****, P < 0.0001. ns, not significant.
C57bl/6 Murine Bone Marrow Derived Primary Macrophages (Bmdm, supplied by Cell Biologics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c57bl/6 murine bone marrow-derived primary macrophages (bmdm/product/Cell Biologics Inc
Average 90 stars, based on 1 article reviews
c57bl/6 murine bone marrow-derived primary macrophages (bmdm - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Jackson Laboratory primary murine bone marrow derived macrophages (bmdms) from wild-type c57bl/6j mice
Increased survival from AuNP-OpcP-LPS- or AuNP-OpcP1-LPS-immunized mice against a lethal intranasal challenge with B. pseudomallei K96243. (A) Graphical representation of the vaccination, challenge, and organ/tissue collection timeline. Two separate groups of <t>C57BL/6</t> mice (at least n = 9) were immunized intranasally 3× in 2-week intervals with formulations containing 10 μg of protein, 10 μg of LPS, and 20 μg of CpG ODN 2395. In experiment one, a combination formulation (AuNP-Combo1-LPS) included equivalent amounts of protein (Hcp1, OmpW, OpcP, OpcP1, FlgL, and HA) from each candidate for a total of 10 μg of protein. A second animal experiment (at least n = 9) was conducted to evaluate histopathology, cell-mediated response, and BALF from vaccinated-only animals. (B) In experiment one, 3 weeks after the last vaccination, animals were challenged with 6 LD 50 (9.0 × 10 4 CFU per mouse) of B. pseudomallei K96243. (C to E) Lungs (C), livers (D), and spleens (E) of surviving animals were collected at 35 days postinfection to evaluate bacterial infection. Bacterial load was determined per gram of tissue, and representative panels for colonization are shown on log scale. All colonization data are shown as means ± standard errors of the means (SEM) of results determined per group. Statistical analyses were determined using the Kaplan-Meier method, followed by log rank test. Levels of significance compared to the adjuvant-only group: ***, P < 0.001; ****, P < 0.0001. ns, not significant.
Primary Murine Bone Marrow Derived Macrophages (Bmdms) From Wild Type C57bl/6j Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary murine bone marrow derived macrophages (bmdms) from wild-type c57bl/6j mice/product/Jackson Laboratory
Average 90 stars, based on 1 article reviews
primary murine bone marrow derived macrophages (bmdms) from wild-type c57bl/6j mice - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Increased survival from AuNP-OpcP-LPS- or AuNP-OpcP1-LPS-immunized mice against a lethal intranasal challenge with B. pseudomallei K96243. (A) Graphical representation of the vaccination, challenge, and organ/tissue collection timeline. Two separate groups of C57BL/6 mice (at least n = 9) were immunized intranasally 3× in 2-week intervals with formulations containing 10 μg of protein, 10 μg of LPS, and 20 μg of CpG ODN 2395. In experiment one, a combination formulation (AuNP-Combo1-LPS) included equivalent amounts of protein (Hcp1, OmpW, OpcP, OpcP1, FlgL, and HA) from each candidate for a total of 10 μg of protein. A second animal experiment (at least n = 9) was conducted to evaluate histopathology, cell-mediated response, and BALF from vaccinated-only animals. (B) In experiment one, 3 weeks after the last vaccination, animals were challenged with 6 LD 50 (9.0 × 10 4 CFU per mouse) of B. pseudomallei K96243. (C to E) Lungs (C), livers (D), and spleens (E) of surviving animals were collected at 35 days postinfection to evaluate bacterial infection. Bacterial load was determined per gram of tissue, and representative panels for colonization are shown on log scale. All colonization data are shown as means ± standard errors of the means (SEM) of results determined per group. Statistical analyses were determined using the Kaplan-Meier method, followed by log rank test. Levels of significance compared to the adjuvant-only group: ***, P < 0.001; ****, P < 0.0001. ns, not significant.

Journal: mBio

Article Title: Multicomponent Gold-Linked Glycoconjugate Vaccine Elicits Antigen-Specific Humoral and Mixed T H 1-T H 17 Immunity, Correlated with Increased Protection against Burkholderia pseudomallei

doi: 10.1128/mBio.01227-21

Figure Lengend Snippet: Increased survival from AuNP-OpcP-LPS- or AuNP-OpcP1-LPS-immunized mice against a lethal intranasal challenge with B. pseudomallei K96243. (A) Graphical representation of the vaccination, challenge, and organ/tissue collection timeline. Two separate groups of C57BL/6 mice (at least n = 9) were immunized intranasally 3× in 2-week intervals with formulations containing 10 μg of protein, 10 μg of LPS, and 20 μg of CpG ODN 2395. In experiment one, a combination formulation (AuNP-Combo1-LPS) included equivalent amounts of protein (Hcp1, OmpW, OpcP, OpcP1, FlgL, and HA) from each candidate for a total of 10 μg of protein. A second animal experiment (at least n = 9) was conducted to evaluate histopathology, cell-mediated response, and BALF from vaccinated-only animals. (B) In experiment one, 3 weeks after the last vaccination, animals were challenged with 6 LD 50 (9.0 × 10 4 CFU per mouse) of B. pseudomallei K96243. (C to E) Lungs (C), livers (D), and spleens (E) of surviving animals were collected at 35 days postinfection to evaluate bacterial infection. Bacterial load was determined per gram of tissue, and representative panels for colonization are shown on log scale. All colonization data are shown as means ± standard errors of the means (SEM) of results determined per group. Statistical analyses were determined using the Kaplan-Meier method, followed by log rank test. Levels of significance compared to the adjuvant-only group: ***, P < 0.001; ****, P < 0.0001. ns, not significant.

Article Snippet: C57BL/6 murine bone marrow-derived primary macrophages (BMDM) (no. C57-6030; Cell Biologics Inc., Chicago, IL) were routinely grown in complete primary cell culture medium by following the manufacturer’s instructions (no. M3368; Cell Biologics).

Techniques: Histopathology, Infection

Intranasal immunization with optimized formulation (AuNP-Combo2-LPS) provides enhanced protection against inhalational melioidosis. C57BL/6 mice (at least n = 9 ) were immunized as described for <xref ref-type=Fig. 1 . The AuNP-Combo2-LPS vaccinated group contained equivalent amounts of protein (OpcP and Opcp1) from each candidate for a total of 10 μg of protein. (A to D) After intranasal challenge with 5 LD 50 (7.5 × 10 4 CFU per mouse) of B. pseudomallei K96243 (A), the lungs (B), livers (C), and spleens (D) of surviving animals were collected at 35 days postinfection, and bacterial enumeration was performed. Bacterial load was determined per gram of tissue, and representative panels for colonization are shown on a log scale. (E) Histopathological analysis from lungs, livers, and spleens of a representative mouse from each surviving group. Lung sections from the AuNP-OpcP-LPS vaccination group showed increased pathological findings compared to the AuNP-OpcP1-LPS and AuNP-Combo2-LPS groups. The liver sections from the AuNP-OpcP-LPS immunization group showed the most inflammation and evidence of liver injury. Spleen sections from surviving animals all showed similar histopathological findings, with the most pronounced in the AuNP-OpcP-LPS vaccine group. At the endpoint of the experiment, tissues were harvested from three mice of the 10 survivors. The tissues were fixed, sectioned, and stained with hematoxylin and eosin. Images are representative of three mice. Scale bar, 500 μm. All colonization data are shown as means ± standard errors of the means (SEM) of results determined per group. Statistical analyses were determined using the Kaplan-Meier method, followed by log rank test. Levels of significance compared to the adjuvant-only group: ***, P < 0.0005; ****, P < 0.0001. ns, not significant. " width="100%" height="100%">

Journal: mBio

Article Title: Multicomponent Gold-Linked Glycoconjugate Vaccine Elicits Antigen-Specific Humoral and Mixed T H 1-T H 17 Immunity, Correlated with Increased Protection against Burkholderia pseudomallei

doi: 10.1128/mBio.01227-21

Figure Lengend Snippet: Intranasal immunization with optimized formulation (AuNP-Combo2-LPS) provides enhanced protection against inhalational melioidosis. C57BL/6 mice (at least n = 9 ) were immunized as described for Fig. 1 . The AuNP-Combo2-LPS vaccinated group contained equivalent amounts of protein (OpcP and Opcp1) from each candidate for a total of 10 μg of protein. (A to D) After intranasal challenge with 5 LD 50 (7.5 × 10 4 CFU per mouse) of B. pseudomallei K96243 (A), the lungs (B), livers (C), and spleens (D) of surviving animals were collected at 35 days postinfection, and bacterial enumeration was performed. Bacterial load was determined per gram of tissue, and representative panels for colonization are shown on a log scale. (E) Histopathological analysis from lungs, livers, and spleens of a representative mouse from each surviving group. Lung sections from the AuNP-OpcP-LPS vaccination group showed increased pathological findings compared to the AuNP-OpcP1-LPS and AuNP-Combo2-LPS groups. The liver sections from the AuNP-OpcP-LPS immunization group showed the most inflammation and evidence of liver injury. Spleen sections from surviving animals all showed similar histopathological findings, with the most pronounced in the AuNP-OpcP-LPS vaccine group. At the endpoint of the experiment, tissues were harvested from three mice of the 10 survivors. The tissues were fixed, sectioned, and stained with hematoxylin and eosin. Images are representative of three mice. Scale bar, 500 μm. All colonization data are shown as means ± standard errors of the means (SEM) of results determined per group. Statistical analyses were determined using the Kaplan-Meier method, followed by log rank test. Levels of significance compared to the adjuvant-only group: ***, P < 0.0005; ****, P < 0.0001. ns, not significant.

Article Snippet: C57BL/6 murine bone marrow-derived primary macrophages (BMDM) (no. C57-6030; Cell Biologics Inc., Chicago, IL) were routinely grown in complete primary cell culture medium by following the manufacturer’s instructions (no. M3368; Cell Biologics).

Techniques: Staining